Earnings call Recursion Pharmaceuticals delivered strong operational progress with a 30% YoY reduction in operating expenses and an extended cash runway into early 2028. Clinical momentum was ...
During Tuesday’s Google I/O keynote, Demis Hassabis, the CEO of Google DeepMind, proclaimed that we are currently “standing ...
Microsoft exposes a cryptojacking campaign using SEO poisoning and ScreenConnect to target high-performance PCs, with ...
Towards the end of 2025, AI systems suddenly became capable of writing entire computer programs on their own, a moment that ...
Discover 25 terrifying things AI can already do that will shock you. From predicting crimes to deepfakes and emotion reading, ...
EPS exceeded forecasts by 15.38%, reflecting effective cost management. Revenue missed expectations by 60.26%, raising concerns about growth prospects. The stock price fell by 5.34% in pre-market ...
Recursion Pharmaceuticals exceeded EPS expectations by 15.38%. The company reported a significant revenue shortfall, missing forecasts by 60.26%. Pre-market stock price fell 1.84% amid broader biotech ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. logos of OpenAI There’s interesting news coming from Sam Altman’s empire, a firm known for ...
UIUC and Stanford's RecursiveMAS lets AI agents collaborate in embedding space instead of text, cutting token usage by 75% ...
Understanding the secret commands that steer the behavior of chatbots like ChatGPT can help you customize them to your needs.
People using a blue inhaler to help treat their asthma are being urged to contact their GP. The call comes after changes in guidelines following research which showed long-term use of the medication ...